Tenascin N anticorps (AA 441-556) (HRP)

N° du produit ABIN7171749

Détail du produit anti-Tenascin N anticorps (HRP)

Antigène: Tenascin N (TNN)

Épitope: AA 441-556

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Tenascin N est conjugé à/à la HRP

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Tenascin-N protein (441-556AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur Tenascin N

Antigène: Tenascin N (TNN)

Autre désignation: TNN (TNN Produits)

Synonymes: anticorps TNW, anticorps tenascin-N, anticorps TNN, anticorps TN-W, anticorps Tnw, anticorps tenascin-W, anticorps tenascin N, anticorps Tnn, anticorps TNN

Sujet:

Background: Extracellular matrix protein that seems to be a ligand for ITGA8:ITGB1, ITGAV:ITGB1 and ITGA4:ITGB1 (By similarity) (PubMed:17909022). Involved in neurite outgrowth and cell migration in hippocampal explants (By similarity). During endochondral bone formation, inhibits proliferation and differentiation of proteoblasts mediated by canonical WNT signaling (By similarity). In tumors, stimulates angiogenesis by elongation, migration and sprouting of endothelial cells (PubMed:19884327). Expressed in most mammary tumors, may facilitate tumorigenesis by supporting the migratory behavior of breast cancer cells (PubMed:17909022).

Aliases: TNN antibody, TNW antibody, Tenascin-N antibody, TN-N antibody, Tenascin-W antibody, TN-W antibody

UniProt: Q9UQP3

Pathways: ACE Inhibitor Pathway